Virtu Financial LLC Ligand Pharmaceuticals Inc Transaction History

Virtu Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$69.53 - $79.33 $204,765 - $233,626	2,945 New	2,945 $212,000
Q4 2020 Feb 24, 2021	SELL	$80.55 - $106.05 $308,264 - $405,853	-3,827 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$89.56 - $126.72 $43,705 - $61,839	488 Added 14.62%	3,827 $365,000
Q2 2020 Aug 07, 2020	BUY	$68.28 - $123.65 $40,421 - $73,200	592 Added 21.55%	3,339 $373,000
Q4 2019 Feb 04, 2020	BUY	$96.94 - $113.59 $49,633 - $58,158	512 Added 22.91%	2,747 $286,000
Q3 2019 Nov 20, 2019	BUY	$86.25 - $120.16 $192,768 - $268,557	2,235 New	2,235 $222,000
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $368,206 - $443,506	-3,429 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$105.93 - $142.47 $197,453 - $265,564	1,864 Added 119.11%	3,429 $431,000
Q4 2018 Jan 16, 2019	BUY	$128.36 - $272.13 $42,872 - $90,891	334 Added 27.13%	1,565 $212,000
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $259,962 - $337,897	1,231 New	1,231 $338,000
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $308,035 - $405,781	-2,222 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$128.36 - $147.04 $474,161 - $543,165	-3,694 Reduced 62.44%	2,222 $304,000
Q3 2017 Nov 20, 2017	BUY	$120.91 - $137.94 $715,303 - $816,053	5,916	5,916 $805,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.